Cardiovascular disease associated with obesity and metabolic syndrome is a major culprit, with antipsychotic-induced weight gain playing a significant role
The effects of GLP-1 and its analogs on energy expenditure are still inconsistent [48]
BerentsenBNagarajaBHTeigeEPLiedGALundervoldAJLundervoldKet al
However, specific studies on semaglutides impact on the pharmacokinetics of these antibiotics are limited, and more research is needed to draw definitive conclusions
Newer medications, including GLP-1 drugs, can help patients successfully lose weight to a lesser degree than bariatric surgery
Because retatrutide is still investigational, important unanswered questions remain about long-term cardiovascular effects, durability of weight loss, ongoing tolerability, and safety across broader patient populations, which is one reason reputable clinics, including Relive Health centers nationwide, are not offering retatrutide at this time
